METROPOLITAN LIFE INSURANCE CO/NY - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 146 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$61,120
+94.9%
1,6510.0%0.00%
+200.0%
Q2 2022$31,352
-29.6%
1,6510.0%0.00%
-50.0%
Q1 2022$44,560
-57.6%
1,651
-64.6%
0.00%
+100.0%
Q4 2021$105,080
-14.0%
4,6640.0%0.00%
-50.0%
Q3 2021$122,243
-18.1%
4,6640.0%0.00%0.0%
Q2 2021$149,295
-9.1%
4,6640.0%0.00%0.0%
Q1 2021$164,219
+9.8%
4,6640.0%0.00%0.0%
Q4 2020$149,574
-14.8%
4,6640.0%0.00%
-33.3%
Q3 2020$175,460
-15.9%
4,6640.0%0.00%
-25.0%
Q2 2020$208,7144,6640.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders